Target intelligence / Profile preview

DSTN pseudogene 2 (DSTNP2)

Target
DSTNP2
Molecular classification
Pseudogene
01

Overview

DSTN pseudogene 2 (DSTNP2) is a transcribed, unprocessed pseudogene located on chromosome 12 (12p13.31) in humans[3][6][13]. While DSTNP2 shares sequence similarity with the functional destrin gene, which is important in actin filament dynamics, DSTNP2 itself does not encode a protein and has no established biological or therapeutic relevance[2][6][9]. It is officially classified as a pseudogene by major genome resources and gene nomenclature committees[13][2][12]. No evidence supports DSTNP2 functioning as a therapeutic target, biomarker, or disease gene. DSTNP2 should not be considered for drug targeting, clinical biomarker use, or disease association due to its pseudogene status and lack of functional protein product[2][6][9][13].

Other names
destrin, actin depolymerizing factor pseudogene 2destrin-2 pseudogeneDESTRIN-2 PSEUDOGENEDSTNP2
02

Mechanism of action

Not applicable (pseudogene, no known mechanism)

03

Biological functions

Other: DSTNP2 has no known biological function, as it is non-coding and does not produce protein
04

Disease associations

Other: DSTNP2 is not known to be directly associated with human diseases
05

Safety considerations

None; DSTNP2 poses no known safety considerations or therapeutic challenges
06

Interacting drugs

None. There are no drugs known to target DSTNP2
07

Biomarkers

None; DSTNP2 is not used as a biomarker

Beyond the preview

Go deeper on DSTN pseudogene 2 (DSTNP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSTN pseudogene 2 (DSTNP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call